Clinical Trials Sponsored by Ambryx Biotechnology

Total 1111 results

EVIVE Biotechnology
Peking University Cancer Hospital & Institute

Unknown

Study of A-319 in Patients With Relapsed or Refractory B-cell Lymphoma (A-319)

Relapsed or Refractory B-cell Lymphoma
M.D. Anderson Cancer Center
Zila Biotechnology, Inc.

Terminated

OraTest in Combination With Visual Examination and Visual Examination Alone

Oropharynx Cancer | Head And Neck Cancer

United States
Pennington Biomedical Research Center
Nerium Biotechnology Inc

Withdrawn

A Blinded Comparison Trial of Two Topical Creams to Reduce Thigh Girth and to Smooth Thigh Skin in Women (ThighCream)

Weight Loss

United States
Zhejiang University
Gracell Biotechnology Shanghai Co., Ltd.

Recruiting

An Exploratory Clinical Study of GC012F Injection for the Treatment of Refractory Generalized Myasthenia Gravis

Refractory Generalized Myasthenia Gravis

China
Shanghai iCELL Biotechnology Co., Ltd, Shanghai...

Not yet recruiting

Safety and Efficacy Study of hAESCs Therapy for aGVHD (aGVHD，hAESCs)

GVHD,Acute
RenJi Hospital
Gracell Biotechnology Shanghai Co., Ltd.

Recruiting

Dual Target CAR-T Cell Treatment for Refractory Systemic Lupus Erythematosus (SLE) Patients

CAR-T Cell Therapy

China
Zhejiang University
Gracell Biotechnology Shanghai Co., Ltd.

Recruiting

Phase I Clinical Study of GC012F Injection in Treatment of Refractory Systemic Lupus Erythematosus

CAR-T

China
Hrain Biotechnology Co., Ltd.
Shanghai Zhongshan Hospital

Recruiting

Human CD19 Targeted T Cells Injection(CD19 CAR-T) Therapy for Relapsed and Refractory B-cell Non-Hodgkin's Lymphoma

B-cell Non-Hodgkin's Lymphoma

China
Xuanwu Hospital, Beijing
Beijing Neoantigen Biotechnology Company

Recruiting

Personalized Vaccine for Patients With Recurrent Malignant Glioma

Malignant Glioma | Recurrent Glioma

China
Peking University Third Hospital
Gracell Biotechnology Ltd.

Not yet recruiting

A Study of GC019F CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALL

B-cell Acute Lymphoblastic Leukemia
Xijing Hospital
Xi'An Yufan Biotechnology Co.,Ltd

Recruiting

CRISPR (HPK1) Edited CD19-specific CAR-T Cells (XYF19 CAR-T Cells) for CD19+ Leukemia or Lymphoma.

Lymphoma, B-Cell | CD19 Positive | Leukemia Lymphocytic Acute (ALL) in Relapse | Leukemia Lymphocytic Acute (All) Refractory

China
Ruijin Hospital
Shanghai Houchao Biotechnology Co., Ltd

Recruiting

Study of High Efficient Killing Cell Therapy for Advanced NSCLC (HEART)

Non Small Cell Lung Cancer

China
Dana-Farber Cancer Institute
Puma Biotechnology, Inc.

Terminated

Neratinib +/- Fulvestrant in HER2+, ER+ Metastatic Breast Cancer

Breast Cancer

United States
Washington University School of Medicine
Cellect Biotechnology

Terminated

ApoGraft for the Prevention of Acute Graft Versus Host Disease in Haploidentical Hematopoietic Cell Transplant Recipients

Acute Graft Versus Host Disease | Haploidentical Hematopoietic Stem Cell Transplant

United States
Hebei Yanda Ludaopei Hospital
Gracell Biotechnology Ltd.

Completed

A Study of GC007F CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALL

B-cell Acute Lymphoblastic Leukemia

China
Hrain Biotechnology Co., Ltd.
Shanghai Changzheng Hospital

Active, not recruiting

Anti-CD19/BCMA Bispecific CAR-T Cell Therapy for R/R POMES

POMES Syndrome | Relapsed and Refractory POMES Syndrome

China
Gazi University
TC Erciyes University; Enbiosis Biotechnology

Completed

The Effect of AI-based Microbiome Diet on IBS-M Symptoms

Irritable Bowel Syndrome Mixed

Turkey
Shanghai Tong Ren Hospital
Gracell Biotechnology Ltd.

Unknown

CD19-targeting CAR T Cells in Relapsed or Refractory CD19 Positive B-cell Malignancies

B-cell Lymphoma | B-cell Malignancy | B-Cell Acute Lymphoblastic Leukaemia

China
Peking University
Shanghai Mingju Biotechnology Co., Ltd.

Unknown

Study Evaluating the Safety and Efficacy of JWCAR029 in Adult Subjects With Relapsed and Refractory B-cell Non-Hodgkin Lymphoma

Non Hodgkin Lymphoma

China
Henan Cancer Hospital
Henan Hualong Biotechnology Company

Unknown

Cord Blood Derived CAR-T Cells in Refractory/Relapsed B Cell Malignancies

B Cell Lymphoma | B Cell Leukemia | Refractory | Relapsed

China
University Hospitals Cleveland Medical Center
CellPrint Biotechnology

Terminated

The Role of Molecules in Blood Cells for Diagnosing Bipolar Disorders

Bipolar Disorder

United States
Ethicon, Inc.
Guangzhou Bioseal Biotechnology Co., Ltd.

Completed

The Bioseal Vascular Study

Hemorrhage | Cardiovascular Bleeding | Vascular Bleeding

China
Changhai Hospital
ImmunoGene Biotechology Co.,Ltd

Unknown

Safety and Efficacy Evaluation of iAPA-DC/CTL Combined Gemcitabine Therapy on Advanced Pancreatic Cancer

Carcinoma, Pancreatic Ductal

China
PRG Science & Technology Co., Ltd.
Amarex Clinical Research

Completed

Phase I Study of Progerinin in Healthy Volunteers

Hutchinson-Gilford Progeria Syndrome | Werner Syndrome

United States
Mayo Clinic
ARYx Therapeutics

Completed

Effect of ATI-7505 on Gastrointestinal Transit in Healthy Volunteers

Healthy

United States
Jennewein Biotechnologie GmbH
Analyze & Realize

Completed

Study Evaluating Growth and Tolerance of Infant Formula Containing HMOs

Infant Nutrition

Italy, Germany, Spain
Peking University
Shanghai Ming Ju Biotechnology Co., Ltd.

Recruiting

MAGE-A4-directed TCR-T in the Treatment Amongst Subjects With Advanced Solid Tumors

Advanced Solid Tumor

China
Shanghai Changzheng Hospital
Gracell Biotechnology Shanghai Co., Ltd.

Recruiting

Study of FasT CAR-T GC012F Injection NDMM Patients

Multiple Myeloma

China
University Hospital, Ghent
Flemish institute of biotechnology (VIB)

Recruiting

Single-Cell Transcriptomics of the Peritoneal Microenvironment of Colorectal PC (SingleCell)

Peritoneal Metastases

Belgium
Shanghai Changzheng Hospital
Gracell Biotechnology Shanghai Co., Ltd.

Recruiting

Study of Dual Targeted CD19/BCMA FASTCART GC012F in Relapsed/ Refractory Multiple Myeloma

Multiple Myeloma

China
Shanghai Changzheng Hospital
Gracell Biotechnology Shanghai Co., Ltd.

Recruiting

BCMA and CD19 Targeted Fast Dual CAR-T for BCMA+ Refractory/Relapsed Multiple Myeloma

Multiple Myeloma

China
Massachusetts General Hospital
Puma Biotechnology, Inc.; Celcuity, Inc.

Withdrawn

Fulvestrant + Neratinib In Breast Cancer (HER2-Signal)

Metastatic Breast Cancer | Invasive Breast Cancer | HER2-negative Breast Cancer | ER Positive Breast Cancer | PR-Positive Breast Cancer | Stage IV (Metastatic) Breast Cancer

United States
Jiangsu Rec-Biotechnology Co., Ltd.
Iqvia Pty Ltd

Completed

Safety, Reactogenicity and Immunogenicity Study of ReCOV

Covid19

New Zealand
BAIYONG SHEN
GeneCast Biotechnology Co., Ltd.

Completed

Molecular Subtyping for Prognosis Evaluation in Resected Pancreatic Adenocarcinoma

Pancreatic Cancer Resectable

China
Shanghai Changzheng Hospital
Gracell Biotechnology Shanghai Co., Ltd.

Unknown

BCMA and CD19 Targeted Fast Dual CART for Chromosomal Abnomalities High-risk BCMA+ Multiple Myeloma

Multiple Myeloma

China
Peking University People's Hospital
San Valley Biotechnology Incorporated

Unknown

Identifying Genomic Mutations of Multiple Primary Lung Cancers by Circulating Tumor DNA

Carcinoma | Thoracic Neoplasms | Non-small-cell Lung Cancer
Fuda Cancer Hospital, Guangzhou
Shengxin Biotechnology Institute, Beijing

Completed

Bioinformation Therapy for Intestinal Cancer

Advanced Intestinal Cancer

China
Fuda Cancer Hospital, Guangzhou
Shengxin Biotechnology Institute, Beijing

Completed

Bioinformation Therapy for Pancreatic Cancer

Unresectable Pancreatic Cancer

China
Fuda Cancer Hospital, Guangzhou
Shengxin Biotechnology Institute, Beijing

Completed

Bioinformation Therapy for Gastric Cancer

Advanced Gastric Cancer

China
Newcastle University
Biotechnology and Biological Sciences Research Council

Completed

Acceptability of Dietary Fibre-based Foods

Obesity
Beijing Sanbo Brain Hospital
Marino Biotechnology Co., Ltd.

Unknown

Pilot Study of Autologous Chimeric Switch Receptor Modified T Cells in Recurrent Glioblastoma Multiforme

Glioblastoma Multiforme

China
Genovate Biotechnology Co., Ltd.,
Otsuka Pharmaceutical Co., Ltd.

Unknown

Improving Cognitive Function of Aripiprazole in Treating Adolescents and Young Adults With Psychotic Disorder

Psychotic Disorders
LXR Biotechnology

Completed

A Study of LXR015-1 in HIV-Infected Patients

HIV Infections

United States
Guangzhou Medical University
Ningbo SensCure Biotechnology Co., Ltd.

Recruiting

Single-center Clinical Study on the Safety and Effect of Bronchoscopic Cryotherapy in Patients With Chronic Cough (ColdCough)

Chronic Cough

China
Hebei Senlang Biotechnology Inc., Ltd.
Cangzhou People's Hospital

Recruiting

CAR-T Cells in the Treatment of Malignant Hematological Tumors

Lymphoma, B-Cell | Multiple Myeloma | Leukemia, T-Cell | Leukemia, B-cell

China
Shanghai Changzheng Hospital
Gracell Biotechnology Shanghai Co., Ltd.

Recruiting

Study of FasT CAR-T GC012F Injection in High Risk TE NDMM Patients

Multiple Myeloma

China
Shanghai 6th People's Hospital
Hrain Biotechnology Co., Ltd.

Recruiting

The Fourth Generation CART-cell Therapy for Refractory-Relapsed Ovarian Cancer

Ovarian Cancer

China
Memorial Sloan Kettering Cancer Center
Puma Biotechnology, Inc.

Active, not recruiting

Capecitabine 7/7 Schedule With Neratinib in Patients With Metastatic HER2-Positive Breast Cancer

Breast Cancer

United States
Vinbiocare Biotechnology Joint Stock Company
Arcturus Therapeutics, Inc.

Completed

The ARCT-154 Self-Amplifying RNA Vaccine Efficacy Study (ARCT-154-01) (ARCT-154-01)

COVID-19 Vaccines

Vietnam
Brii Biosciences Limited
Alnylam Pharmaceuticals; Vir Biotechnology, Inc.

Completed

Study of VIR-2218 in Patients With Chronic Hepatitis B in Mainland China

Hepatitis B, Chronic

China

Clinical Trials Sponsored by Ambryx Biotechnology

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Egypt

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations